Abstract
The Spike (S) protein of the severe acute respiratory syndrome-associated coronavirus (SARS-CoV) plays important roles in viral pathogenesis and potentially in the development of an effective vaccine against this virulent infectious disease. In this study, the codon-optimized S gene of SARS-CoV was synthesized to construct DNA vaccine plasmids expressing either the full-length or segments of the S protein. High titer S-specific immunoglobulin G antibody responses were elicited in rabbits immunized with DNA against various segments of the S protein. Two neutralizing domains were identified on the S protein, one at the N terminus (Ser12-Thr535) and the other near the C terminus (Arg797-Ile1192).
Publication types
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Animals
-
Antibodies, Viral / immunology*
-
Cell Line
-
Chlorocebus aethiops
-
Cytopathogenic Effect, Viral
-
Epitopes / chemistry*
-
Epitopes / immunology
-
Humans
-
Immunization
-
Membrane Glycoproteins / chemistry*
-
Membrane Glycoproteins / immunology*
-
Membrane Glycoproteins / metabolism
-
Neutralization Tests
-
Rabbits
-
Severe Acute Respiratory Syndrome / immunology
-
Severe Acute Respiratory Syndrome / prevention & control
-
Severe acute respiratory syndrome-related coronavirus / immunology*
-
Spike Glycoprotein, Coronavirus
-
Vaccines, DNA / administration & dosage
-
Vaccines, DNA / immunology
-
Vero Cells
-
Viral Envelope Proteins / chemistry*
-
Viral Envelope Proteins / immunology*
-
Viral Envelope Proteins / metabolism
-
Viral Vaccines / administration & dosage
-
Viral Vaccines / immunology
Substances
-
Antibodies, Viral
-
Epitopes
-
Membrane Glycoproteins
-
Spike Glycoprotein, Coronavirus
-
Vaccines, DNA
-
Viral Envelope Proteins
-
Viral Vaccines
-
spike glycoprotein, SARS-CoV
-
spike protein, mouse hepatitis virus